WARFARIN SENSITIVITY (disorder)
|
phenotype |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
10
|
8
|
0.020 |
None |
1.000 |
2 |
|
2013 |
2015 |
Vitamin K Assay
|
phenotype |
|
Laboratory Procedure
|
3
|
6
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Vitamin E Assay
|
phenotype |
|
Laboratory Procedure
|
3
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Venous Thromboembolism
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
378
|
408
|
0.020 |
None |
1.000 |
2 |
|
2010 |
2012 |
Vascular Diseases
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
688
|
40
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Varicosity
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
188
|
51
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Stable angina
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
144
|
8
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
5
|
2013 |
2013 |
Prosthetic Valve Thrombosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
8
|
|
0.010 |
None |
< 0.001 |
1 |
|
2019 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.010 |
None |
< 0.001 |
1 |
1
|
2012 |
2012 |
Post transplant diabetes mellitus
|
disease |
|
Disease or Syndrome
|
21
|
11
|
0.010 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
PATENT DUCTUS ARTERIOSUS 1
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
229
|
12
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Patent ductus arteriosus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
510
|
56
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Pancreatic Ductal Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
970
|
22
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Non-Neoplastic Disorder
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
50
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Non-alcoholic Fatty Liver Disease
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1058
|
222
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Myocardial Infarction
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
1800
|
680
|
0.010 |
None |
1.000 |
1 |
2
|
2009 |
2009 |
Metabolic Syndrome X
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1125
|
591
|
0.020 |
None |
1.000 |
2 |
1
|
2012 |
2017 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.010 |
None |
< 0.001 |
1 |
1
|
2012 |
2012 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |